HomeZVRA • NASDAQ
add
Zevra Therapeutics Inc
Previous close
$7.32
Day range
$7.19 - $7.68
Year range
$4.20 - $9.75
Market cap
414.53M USD
Avg Volume
461.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 12.04M | -6.79% |
Operating expense | 26.09M | -2.82% |
Net income | -35.74M | -79.67% |
Net profit margin | -296.76 | -92.75% |
Earnings per share | -0.69 | -72.50% |
EBITDA | -13.77M | 4.19% |
Effective tax rate | -75.47% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 69.50M | 2.60% |
Total assets | 178.13M | 3.37% |
Total liabilities | 138.46M | 25.35% |
Total equity | 39.67M | — |
Shares outstanding | 54.12M | — |
Price to book | 9.89 | — |
Return on assets | -20.85% | — |
Return on capital | -33.56% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -35.74M | -79.67% |
Cash from operations | -16.25M | -0.57% |
Cash from investing | -5.47M | -151.69% |
Cash from financing | 796.00K | -84.09% |
Net change in cash | -20.25M | -9,106.36% |
Free cash flow | -12.07M | -129.51% |
About
Founded
2006
Website
Employees
59